Faculty of Public Health - Andalas University - OCS, 13th IEA SEA Meeting and ICPH - SDev

Font Size: 
Health care cost of depression in primary patient care in North India: A pharmacoeconomic study
Mani Goel, Shubhanshu Gupta

Last modified: 2018-07-30


Background: Depression and anxiety disorders are the most common mental illnesses, each affecting more than 10-15% of the population at some time in their lives. The present study aims at cost analysis of antidepressants in a developing country.

Methods: It was a hospital based economic evaluation done for period of one year at OPD of MLB medical college. Computerized record system was used to identify the patients with depression and they were treated with anti-depressants drug therapy. The relative cost was quantified as the average percentage of the per capita gross national product (GNP/capita) every person spent for Antidepressant drug treatment.

Results: Patients with depression had higher annual health care costs. The overall cost of treatment for the whole sample was estimated at approximately Rs. 3.17 lakhs. Whereas the average cost of efficacious treatment for a continuous period of 1 year was lowest for fluoxetine.

Conclusions: Recurrent use of relatively expensive drugs has heightened the cost of Antidepressant drug therapy for patients. The supervision of the marketing drugs should be concentrated towards maximizing the therapeutic aids to the community.

Acknowledgement- Sincere Gratitude to Dr. Sadhana Kaushik and Hospital Team.

Key Words: Depression, Antidepressant drugs, cost, epidemiology